25 results
8-K
EX-99.1
ADPT
Adaptive Biotechnologies Corp
3 Nov 22
Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results
4:16pm
growth and innovation across our businesses with a clear path to profitability.”
Recent Highlights
Revenue of $47.8 million for the third quarter
8-K
EX-99.1
cmw5v6lq7rf
17 Mar 21
Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen
4:31pm
424B5
d9rw pejji0504
16 Jul 20
Prospectus supplement for primary offering
4:26pm
424B5
ems6re110jjd5wtwc 11
14 Jul 20
Prospectus supplement for primary offering
5:01pm
8-K
EX-99.1
qq1x7ut
5 May 20
Regulation FD Disclosure
12:00pm
DEF 14A
zdcvfi
24 Apr 20
Definitive proxy
4:15pm
8-K
EX-99.1
qalf04g6
20 Mar 20
Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access
2:13pm
10-K
mpx l12zmwa
26 Feb 20
Annual report
4:53pm
424B4
cch 00uku6hvf5h2b139
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
uafbu
9 Jan 20
Draft registration statement
12:00am
424B4
za9xb9qk4pvy m5li1se
27 Jun 19
Prospectus supplement with pricing info
5:24pm